Treatment of a patient with genotype 7 hepatitis C virus infection with sofosbuvir and velpatasvir

Hepatology

Volumn 64, Issue 3, 2016, Pages 983-985

  Schreiber, Jonas ^a   McNally, John ^b   Chodavarapu, Krishna ^b   Svarovskaia, Evguenia ^b   Moreno, Christophe ^a  

^a ERASME HOSPITAL   (Belgium)

^b GILEAD SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; SOFOSBUVIR PLUS VELPATASVIR;

ADULT; ANTIVIRAL THERAPY; CASE REPORT; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS C VIRUS GENOTYPE 7; HUMAN; MALE; NOTE; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE; VIRUS LOAD;

EID: 84987899470     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.28636     Document Type: Note

References (5)

1. 47Feld JJ, Jacobson IM, Hezode, C, Assehah T, Ruane PJ, Gruener N, et al. Sofosbuvir and velpatasvir for HCV genotype 1, 2, 4, 5, and 6 infection. N Engl J Med 2015;373:2599-2607.
2. Smith DB, Bukh J, Kuiken C, Muerhoff AS, Rice CM, Stapleton JT, et al. Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource. Hepatology 2014;59:318-327.
3. Hedskog C, Chodavarapu K, Ku KS, Xu S, Martin R, Miller MD, et al. Genotype- and subtype-independent full-genome sequencing assay for hepatitis C virus. J Clin Microbiol 2015;53: 2049-2059.
4. Murphy DG, Sablon E, Chamberland J, Fournier E, Dandavino R, Tremblay CL. Hepatitis C virus genotype 7, a new genotype originating from central Africa. J Clin Microbiol 2015;53:967-972.
5. Foster GR, Afdhal N, Roberts SK, Brau N, Gane EJ, Pianko S, et al. Sofosbuvir and velpatasvir for HCV genotype 2 and 3 infection. New Engl J Med 2015;373:2608-2617.